ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2905

The IL-6/Th17 Axis Promotes Autoantibody-Associated Autoimmune Valvular Carditis in Mice

Jennifer L. Auger1, Brianna J. Engelson2, Yaya Wang3, Erik J. Peterson4 and Bryce A. Binstadt5, 1Center for Immunology and Department of Pediatrics, University of Minnesota, Minneapolis, MN, 2Pediatrics, University of Minnesota, Minneapolis, MN, 3Medicine, University of Minnesota, Minneapolis, MN, 4University of Minnesota, Minneapolis, MN, 5Pediatric Rheumatology, University of Minnesota, Minneapolis, MN

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Animal models, Heart disease, IL-6, macrophages and rheumatoid arthritis, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Autoimmune valvular carditis occurs in patients with systemic lupus erythematosus, rheumatoid arthritis and rheumatic fever, but the pathogenic mechanisms remain incompletely defined. Spontaneous autoimmune valvular carditis develops in the K/BxN T cell receptor transgenic mouse model of autoantibody-dependent inflammatory arthritis.  CD4 T helper (Th) cells and macrophages cooperate to promote carditis in this model. We investigated which effector Th cell population was the predominant driver of cardiovascular pathology in K/BxN mice.

Methods:

We first used RT-PCR to measure key cytokine transcript levels in cardiac valves of arthritic K/BxN mice and controls.  We then used anti-cytokine blocking antibodies and gene knockout mice to determine which Th effector cells and cytokines were most critical for valve inflammation.

Results:

We found increased expression of the genes encoding the Th17 differentiation factor IL-6 and IL-17A itself in K/BxN mitral valves relative to controls; IL-4 and IFNγ transcript levels were not different.  Antibody blockade of IL-6 or IL-17A reduced the severity of valve inflammation, whereas blocking IL-4 had no effect.  Genetic deficiency of IFNγ did not affect carditis severity.  K/BxN mice lacking the key Th17 transcription factor RORγt had delayed onset of arthritis and were protected from valvular carditis.

Conclusion:

Th17 cells are key drivers of autoimmune valvular carditis in K/BxN mice. We suggest a model in which autoantibodies engage Fc receptors on macrophages, leading to IL-6 production, which in turn promotes the differentiation of valve-infiltrating Th17 effector cells.  Our results provide new insight into the mechanisms of valvular carditis in systemic autoantibody-mediated rheumatic diseases.  More broadly, these findings may help guide the selection of therapies to reduce cardiovascular morbidity and mortality among patients with rheumatoid arthritis and systemic lupus erythematosus.


Disclosure:

J. L. Auger,
None;

B. J. Engelson,
None;

Y. Wang,
None;

E. J. Peterson,
None;

B. A. Binstadt,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-il-6th17-axis-promotes-autoantibody-associated-autoimmune-valvular-carditis-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology